Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity.Ronald G. Steis, John Edward McKnight, Robin Lin Miller et al.|Journal of Clinical Oncology|1990Cited by 106
Interleukin 2 and lymphokine-activated killer cell therapy: analysis of a bolus interleukin 2 and a continuous infusion interleukin 2 regimen.Jeffrey W. Clark, Stephen P. Creekmore, John W. Smith et al.|PubMed|1990Cited by 54
Randomized trial of recombinant alpha 2b-interferon with or without indomethacin in patients with metastatic malignant melanoma.Robin Lin Miller, W J Urba, DL Longo et al.|PubMed|1989Cited by 38